119 related articles for article (PubMed ID: 19090739)
1. Selective or targeted gene/drug delivery for liver tumors: advantages and current status of local delivery.
Kim YI; Chung JW
Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):791-802. PubMed ID: 19090739
[TBL] [Abstract][Full Text] [Related]
2. Targeted nucleic acid delivery into tumors: new avenues for cancer therapy.
Wagner E; Kircheis R; Walker GF
Biomed Pharmacother; 2004 Apr; 58(3):152-61. PubMed ID: 15082337
[TBL] [Abstract][Full Text] [Related]
3. Radiation-guided drug delivery systems.
Stacy DR; Lu B; Hallahan DE
Expert Rev Anticancer Ther; 2004 Apr; 4(2):283-8. PubMed ID: 15056058
[TBL] [Abstract][Full Text] [Related]
4. Recent developments in carbohydrate-decorated targeted drug/gene delivery.
Zhang H; Ma Y; Sun XL
Med Res Rev; 2010 Mar; 30(2):270-89. PubMed ID: 19626595
[TBL] [Abstract][Full Text] [Related]
5. Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.
Klutz K; Russ V; Willhauck MJ; Wunderlich N; Zach C; Gildehaus FJ; Göke B; Wagner E; Ogris M; Spitzweg C
Clin Cancer Res; 2009 Oct; 15(19):6079-86. PubMed ID: 19789324
[TBL] [Abstract][Full Text] [Related]
6. Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: looking for the grail.
Juillerat-Jeanneret L; Schmitt F
Med Res Rev; 2007 Jul; 27(4):574-90. PubMed ID: 17022028
[TBL] [Abstract][Full Text] [Related]
7. New routes for delivery of anti-epileptic medications.
Fisher RS; Chen DK
Acta Neurol Taiwan; 2006 Dec; 15(4):225-31. PubMed ID: 17214084
[TBL] [Abstract][Full Text] [Related]
8. Bio and nanotechnological strategies for tumor-targeted gene therapy.
Kang JH; Toita R; Katayama Y
Biotechnol Adv; 2010; 28(6):757-63. PubMed ID: 20541598
[TBL] [Abstract][Full Text] [Related]
9. ["Disease targeting therapy" for neurosurgical disorders: molecular targeting and drug delivery].
Saito R; Kumabe T; Tominaga T
No Shinkei Geka; 2006 Nov; 34(11):1157-65. PubMed ID: 17087271
[TBL] [Abstract][Full Text] [Related]
10. Advanced drug delivery systems that target the vascular endothelium.
Ding BS; Dziubla T; Shuvaev VV; Muro S; Muzykantov VR
Mol Interv; 2006 Apr; 6(2):98-112. PubMed ID: 16565472
[TBL] [Abstract][Full Text] [Related]
11. Rifampicin as an oral angiogenesis inhibitor targeting hepatic cancers.
Shichiri M; Fukai N; Kono Y; Tanaka Y
Cancer Res; 2009 Jun; 69(11):4760-8. PubMed ID: 19458074
[TBL] [Abstract][Full Text] [Related]
12. Specifically targeted gene therapy for small-cell lung cancer.
Christensen CL; Zandi R; Gjetting T; Cramer F; Poulsen HS
Expert Rev Anticancer Ther; 2009 Apr; 9(4):437-52. PubMed ID: 19374598
[TBL] [Abstract][Full Text] [Related]
13. Ligand-based targeted therapy for cancer tissue.
Das M; Mohanty C; Sahoo SK
Expert Opin Drug Deliv; 2009 Mar; 6(3):285-304. PubMed ID: 19327045
[TBL] [Abstract][Full Text] [Related]
14. Strategies for short hairpin RNA delivery in cancer gene therapy.
Wang SL; Yao HH; Qin ZH
Expert Opin Biol Ther; 2009 Nov; 9(11):1357-68. PubMed ID: 19761417
[TBL] [Abstract][Full Text] [Related]
15. Strategies to improve drug delivery in bladder cancer therapy.
Wirth M; Plattner VE; Gabor F
Expert Opin Drug Deliv; 2009 Jul; 6(7):727-44. PubMed ID: 19538035
[TBL] [Abstract][Full Text] [Related]
16. Cell vehicle targeting strategies.
Roth JC; Curiel DT; Pereboeva L
Gene Ther; 2008 May; 15(10):716-29. PubMed ID: 18369326
[TBL] [Abstract][Full Text] [Related]
17. Delivery of DNA into muscle for treating systemic diseases: advantages and challenges.
Trollet C; Scherman D; Bigey P
Methods Mol Biol; 2008; 423():199-214. PubMed ID: 18370200
[TBL] [Abstract][Full Text] [Related]
18. Drug targeting to the diseased liver.
Poelstra K; Prakash J; Beljaars L
J Control Release; 2012 Jul; 161(2):188-97. PubMed ID: 22370583
[TBL] [Abstract][Full Text] [Related]
19. Magnetically modulated therapeutic systems.
Häfeli UO
Int J Pharm; 2004 Jun; 277(1-2):19-24. PubMed ID: 15158965
[TBL] [Abstract][Full Text] [Related]
20. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
Ma XJ; Huang R; Kuang AR
Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
